Report Detail

Other Global Noninvasive Prenatal Diagnostics Market Size, Status and Forecast 2019-2025

  • RnM3453822
  • |
  • 25 June, 2019
  • |
  • Global
  • |
  • 93 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Services
      • 1.4.3 Instrument
    • 1.5 Market by Application
      • 1.5.1 Global Noninvasive Prenatal Diagnostics Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Personal
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Noninvasive Prenatal Diagnostics Market Size
    • 2.2 Noninvasive Prenatal Diagnostics Growth Trends by Regions
      • 2.2.1 Noninvasive Prenatal Diagnostics Market Size by Regions (2014-2025)
      • 2.2.2 Noninvasive Prenatal Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Noninvasive Prenatal Diagnostics Market Size by Manufacturers
      • 3.1.1 Global Noninvasive Prenatal Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Noninvasive Prenatal Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Noninvasive Prenatal Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Noninvasive Prenatal Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Noninvasive Prenatal Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 5.2 Noninvasive Prenatal Diagnostics Key Players in United States
    • 5.3 United States Noninvasive Prenatal Diagnostics Market Size by Type
    • 5.4 United States Noninvasive Prenatal Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 6.2 Noninvasive Prenatal Diagnostics Key Players in Europe
    • 6.3 Europe Noninvasive Prenatal Diagnostics Market Size by Type
    • 6.4 Europe Noninvasive Prenatal Diagnostics Market Size by Application

    7 China

    • 7.1 China Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 7.2 Noninvasive Prenatal Diagnostics Key Players in China
    • 7.3 China Noninvasive Prenatal Diagnostics Market Size by Type
    • 7.4 China Noninvasive Prenatal Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 8.2 Noninvasive Prenatal Diagnostics Key Players in Japan
    • 8.3 Japan Noninvasive Prenatal Diagnostics Market Size by Type
    • 8.4 Japan Noninvasive Prenatal Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 9.2 Noninvasive Prenatal Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Type
    • 9.4 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Application

    10 India

    • 10.1 India Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 10.2 Noninvasive Prenatal Diagnostics Key Players in India
    • 10.3 India Noninvasive Prenatal Diagnostics Market Size by Type
    • 10.4 India Noninvasive Prenatal Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Noninvasive Prenatal Diagnostics Market Size (2014-2019)
    • 11.2 Noninvasive Prenatal Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Noninvasive Prenatal Diagnostics Market Size by Type
    • 11.4 Central & South America Noninvasive Prenatal Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Natera
      • 12.1.1 Natera Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.1.5 Natera Recent Development
    • 12.2 Illumina
      • 12.2.1 Illumina Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.2.5 Illumina Recent Development
    • 12.3 BGI Diagnosis
      • 12.3.1 BGI Diagnosis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.3.5 BGI Diagnosis Recent Development
    • 12.4 Ariosa Diagnostics
      • 12.4.1 Ariosa Diagnostics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.4.5 Ariosa Diagnostics Recent Development
    • 12.5 Quest Diagnostics
      • 12.5.1 Quest Diagnostics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.5.5 Quest Diagnostics Recent Development
    • 12.6 Premaitha Health
      • 12.6.1 Premaitha Health Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.6.5 Premaitha Health Recent Development
    • 12.7 NIPD Genetics
      • 12.7.1 NIPD Genetics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.7.5 NIPD Genetics Recent Development
    • 12.8 Labcorp
      • 12.8.1 Labcorp Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.8.5 Labcorp Recent Development
    • 12.9 Ravgen
      • 12.9.1 Ravgen Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.9.5 Ravgen Recent Development
    • 12.10 LifeCodexx
      • 12.10.1 LifeCodexx Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Noninvasive Prenatal Diagnostics Introduction
      • 12.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2014-2019)
      • 12.10.5 LifeCodexx Recent Development
    • 12.11 TrovaGene
    • 12.12 Quest Diagnostics
    • 12.13 Berry Genomics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.
      North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest growth.
      In 2018, the global Noninvasive Prenatal Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Noninvasive Prenatal Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Noninvasive Prenatal Diagnostics development in United States, Europe and China.

      The key players covered in this study
      Natera
      Illumina
      BGI Diagnosis
      Ariosa Diagnostics
      Quest Diagnostics
      Premaitha Health
      NIPD Genetics
      Labcorp
      Ravgen
      LifeCodexx
      TrovaGene
      Quest Diagnostics
      Berry Genomics

      Market segment by Type, the product can be split into
      Services
      Instrument

      Market segment by Application, split into
      Hospital
      Personal
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Noninvasive Prenatal Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Noninvasive Prenatal Diagnostics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Noninvasive Prenatal Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Noninvasive Prenatal Diagnostics. Industry analysis & Market Report on Noninvasive Prenatal Diagnostics is a syndicated market report, published as Global Noninvasive Prenatal Diagnostics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Noninvasive Prenatal Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,968.35
      4,452.53
      5,936.70
      3,518.91
      5,278.36
      7,037.82
      423,633.60
      635,450.40
      847,267.20
      277,988.10
      416,982.15
      555,976.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report